Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL646063 | 0.78 | GAA (0.36) | GAAMEN1KMT2AALDH1A1 | |
| SCHEMBL2021977 | 0.76 | — | — | |
| SCHEMBL2017813 | 0.74 | — | — | |
| SCHEMBL6813743 | 0.72 | GAA (0.35) | GAAMEN1KMT2A | |
| SCHEMBL13009231 | 0.71 | GAA (0.33) | GAAMEN1KMT2A | |
| SCHEMBL7473797 | 0.69 | NAAA (0.42) | GAAMEN1KMT2AALDH1A1 | |
| SCHEMBL14310769 | 0.68 | — | — | |
| SCHEMBL2022920 | 0.67 | CYP2C9 (0.33) | — | |
| SCHEMBL647198 | 0.63 | GAA (0.43) | GAAMEN1KMT2AALDH1A1 | |
| SCHEMBL8407499 | 0.62 | GAA (0.33) | GAAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8481726-B2 | Process for the preparation of sterically hindered nitroxyl ethers | BASF SE (DE) | 2013-07-09 | — | — | US | disclosed |
| US-8481726-B2 | Process for the preparation of sterically hindered nitroxyl ethers | BASF SE (DE) | 2013-07-09 | — | — | US | disclosed |
| US-8481726-B2 | Process for the preparation of sterically hindered nitroxyl ethers | BASF SE (DE) | 2013-07-09 | — | — | US | disclosed |
| US-8471031-B2 | Process for the preparation of sterically hindered nitroxyl ethers | BASF SE (DE) | 2013-06-25 | — | — | US | disclosed |
| US-8471031-B2 | Process for the preparation of sterically hindered nitroxyl ethers | BASF SE (DE) | 2013-06-25 | — | — | US | disclosed |
| US-20110160453-A1 | Process for the preparation of sterically hindered nitroxyl ethers | CIBA CORPORATION | 2011-06-30 | — | — | US | disclosed |
| US-20110160453-A1 | Process for the preparation of sterically hindered nitroxyl ethers | CIBA CORPORATION | 2011-06-30 | — | — | US | disclosed |
| US-20110160453-A1 | Process for the preparation of sterically hindered nitroxyl ethers | CIBA CORPORATION | 2011-06-30 | — | — | US | disclosed |
| US-20100249401-A1 | Process for the preparation of sterically hindered nitroxyl ethers | BASF SE (DE) | 2010-09-30 | — | — | US | disclosed |
| US-20100249401-A1 | Process for the preparation of sterically hindered nitroxyl ethers | BASF SE (DE) | 2010-09-30 | — | — | US | disclosed |
| EP-2035382-B1 | PROCESS FOR THE PREPARATION OF STERICALLY HINDERED NITROXYL ETHERS | BASF SE (DE) | 2009-11-18 | — | — | EP | disclosed |
| EP-2035382-B1 | PROCESS FOR THE PREPARATION OF STERICALLY HINDERED NITROXYL ETHERS | BASF SE (DE) | 2009-11-18 | — | — | EP | disclosed |
| EP-2035382-A1 | PROCESS FOR THE PREPARATION OF STERICALLY HINDERED NITROXYL ETHERS | Ciba Holding Inc. (CH) | 2009-03-18 | — | — | EP | disclosed |
| WO-2008003602-A1 | PROCESS FOR THE PREPARATION OF STERICALLY HINDERED NITROXYL ETHERS | CIBA HOLDING INC. (CH) | 2008-01-10 | — | — | WO | disclosed |
| WO-2008003605-A1 | PROCESS FOR THE PREPARATION OF STERICALLY HINDERED NITROXYL ETHERS | CIBA HOLDING INC. (CH) | 2008-01-10 | — | — | WO | disclosed |
| WO-2008003605-A1 | PROCESS FOR THE PREPARATION OF STERICALLY HINDERED NITROXYL ETHERS | CIBA HOLDING INC. (CH) | 2008-01-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100249401-A1 | Process for the preparation of sterically hindered nitroxyl ethers | PPOX, CBR1, CBR3 | GAA 1862/4885MEN1 4841/4885KMT2A 2110/4885 |
| US-20110160453-A1 | Process for the preparation of sterically hindered nitroxyl ethers | PPOX, CBR1, CBR3 | GAA 1010/4885MEN1 4871/4885KMT2A 1911/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.